Trials / Completed
CompletedNCT01366352
Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets
Pharmacokinetics and Bioavailability Comparison of Two Different Formulations of MNTX Tablets: A Double-Blind, Single Dose, Crossover, Phase 1 Study in Normal Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Bausch Health Americas, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This was a single-center, double-blind, randomized, cross-over Phase 1 study in normal, healthy volunteers. Study treatment entailed single doses of two different formulations of MNTX tablets.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MNTX tablet (Formulation 1) | |
| DRUG | MNTX tablet (Formulation 2) |
Timeline
- Start date
- 2004-02-01
- Primary completion
- 2004-03-01
- Completion
- 2004-03-01
- First posted
- 2011-06-06
- Last updated
- 2019-11-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01366352. Inclusion in this directory is not an endorsement.